Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2559-2561

  Frank, Uwe K ^a   Schmidt Eisenlohr, E ^a   Mlangeni, D ^a   Schindler, M ^a   Hoh, A ^a   Beyersdorf, F ^a   Daschner, F D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; TEICOPLANIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG PENETRATION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE SURGERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; OPEN HEART SURGERY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TISSUE DISTRIBUTION; WOUND INFECTION;

EID: 0030666548     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2559     Document Type: Article

References (13)

1. Bailey, E. M., M. J. Rybak, and G. W. Kaatz. 1991. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin. Antimicrob. Agents Chemother. 35:1089-1092.
2. Bennett, J. V., J. L. Brodie, E. J. Benner, and W. M. M. Kirby. 1966. Simplified, accurate method for antibiotic assay of clinical specimens. Appl. Microbiol. 14:170-177.
3. Daschner, F. D., U. Frank, A. Kümmel, E. Schmidt-Eisenlohr, V. Schlosser, G. Spillner, and M. Schindler. 1987. Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery. J. Antimicrob. Chemother. 19:359-362.
4. Del Favero, A., L. Patoia, R. Rosina, G. Buniva, A. Danese, A. Bernareggi, E. Molini, and L. Cavenaghi. 1991. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses. Antimicrob. Agents Chemother. 35:2551-2557.
5. Frank, U., I. Kappstein, E. Schmidt-Eisenlohr, V. Schlosser, G. Spillner, M. Schindler, and F. D. Daschner. 1987. Penetration of ceftazidime into heart valves and subcutaneous and muscle tissue of patients undergoing open-heart surgery. Antimicrob. Agents Chemother. 31:813-814.
6. Frank, U., E. Schmidt-Eisenlohr, V. Schlosser, G. Spillner, M. Schindler, and F. D. Daschner. 1988. Concentrations of flucloxacillin in heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery. Antimicrob. Agents Chemother. 32:930-931.
7. Goldstein, F. W., A. Coutrot, A. Sieffer, and J. F. Acar. 1990. Percentages and distributions of teicoplanin-and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob. Agents Chemother. 34:899-900.
8. Gorzynski, E. A., D. Amsterdam, T. R. Beam, Jr., and C. Rotstein. 1989. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci. Antimicrob. Agents Chemother. 33:2019-2022.
9. Martin, C., P. Bourget, M. Alaya, A. Sertin, C. Atlani, K. Ennabli, and R. Said. 1997. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac mediastinal tissues. Antimicrob. Agents Chemother. 41:1150-1155.
10. Rowland, M. 1990. Clinical pharmacokinetics of teicoplanin. Clin. Pharmacokinet. 18:184-209.
11. Sharpe, A. N., and A. K. Jackson. 1972. Stomaching: a new concept in bacteriological sample preparation. Appl. Microbiol. 24:175-178.
12. Shea, K. W., and B. A. Cunha. 1995. Teicoplanin. Med. Clin. North Am. 79:833-844.
13. Smithers, J. A., H. K. Kulmala, G. A. Thompson, K. K. Antony, E. W. Lewis, S. J. Ruberg, M. T. Kenny, J. K. Dulworth, and M. A. Brackman. 1992. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers. Antimicrob. Agents Chemother. 36:115-120.